NASDAQ · Consumer discretionary

Medirom Healthcare Technologies Inc. (MRM)

Medirom Healthcare Technologies Inc. reported revenue of ¥8.3B in fiscal 2024, up 21.5% from a year earlier. Net income was ¥148.8M, a net margin of 1.8%. In fiscal 2024 capital spending exceeded operating cash flow by ¥1.4B. At December 31, 2024 it held ¥329.4M in cash against ¥1.4B of debt.

Price

$0.74

-1.32% on the day · September 25, 2026

52-week range $0.70 to $2.85

Market cap

$5.8M

Revenue (FY2024)

¥8.3B

+21.5% year on year

Net margin

1.8%

What Medirom Healthcare Technologies Inc. does

Medirom Healthcare Technologies Inc. is registered with the SEC under industry code SIC 7200 (Services-Personal Services). Its shares trade on NASDAQ under the ticker MRM.

Revenue and profit by year

Revenue

Net income

Fiscal years as reported in annual reports. Amounts in JPY.

Key figures

Fiscal year	Revenue	Operating income	Net income	Diluted EPS	Free cash flow
2024	¥8.3B	-¥18.1M	¥148.8M	¥28.52	-¥1.4B
2023	¥6.8B	-¥391.6M	¥115.4M	¥22.34	-¥767.6M
2022	¥7B	¥97M	¥149M	¥27.23	-¥806.4M
2021	¥5.4B	-¥470.6M	-¥990.7M	-¥203.13	-¥652.9M
2020	¥3.3B	-¥746.1M	-¥539.2M	-¥133.97	-¥440M
2020	¥3.9B	¥34.4M	¥17.3M	¥4.06	¥464K

Full financial statements: income, balance sheet and cash flow

Where MRM ranks in Consumer discretionary

Revenue growth+21.5%

#124 of 887 in Consumer discretionary · Top 14%

Net margin1.8%

#500 of 901 in Consumer discretionary · Bottom 45%

Free cash flow margin-16.9%

#739 of 796 in Consumer discretionary · Bottom 7%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Consumer discretionary

Latest SEC filings

What Medirom Healthcare Technologies Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

August 28, 2026
Activist stake changed SCHEDULE 13D/A
August 27, 2026
Foreign issuer update 6-K
August 27, 2026
Foreign issuer update 6-K
August 7, 2026
Foreign issuer update 6-K
August 7, 2026
Foreign issuer update 6-K
July 17, 2026
Activist stake changed SCHEDULE 13D/A
June 25, 2026
Foreign issuer update 6-K
May 29, 2026
Foreign issuer update 6-K
May 28, 2026
Foreign issuer update 6-K
April 30, 2026
Form NT 20-F filing NT 20-F

Recent insider filings (Forms 3, 4 and 144): 6, the latest on August 28, 2026. Insider transactions on SEC

Insider trades

What the people running Medirom Healthcare Technologies Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider bought or sold shares on the open market in the last 90 days. The 1 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.

Bought (open market)

last 90 days

Sold

last 90 days

Date	Insider	What	Shares	Price	Value	Filing
August 27, 2026	Eguchi KoujiChief Executive Officer, Director, 10% owner	Other change	79,945	-	-	Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns MRM

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

Holder	Of class	Shares	Filed
Kouji Eguchi13D, may seek influence with 1 related filers	25.11%	2,031,558	August 28, 2026

Latest filings below 5%: Kufu Company Holdings, Inc. 0% (July 17, 2026).

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

1 insiders reported holding 1,797,515 shares in total, about $1.3M at the last price.

Holder	Shares	As of
Eguchi KoujiChief Executive Officer, Director, 10% owner	1,797,515	August 27, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about MRM

What does Medirom Healthcare Technologies Inc. do?

Medirom Healthcare Technologies Inc. is registered with the SEC under industry code SIC 7200 (Services-Personal Services). Its shares trade on NASDAQ under the ticker MRM.

Is Medirom Healthcare Technologies Inc. profitable?

Yes. In fiscal 2024 it reported net income of ¥148.8M on revenue of ¥8.3B, a net margin of 1.8%.

How much revenue does Medirom Healthcare Technologies Inc. make?

In fiscal 2024 Medirom Healthcare Technologies Inc. reported revenue of ¥8.3B. That is 21.5% more than a year earlier.

When did Medirom Healthcare Technologies Inc. last report?

Its newest filing of any kind is the activist stake changed from August 28, 2026.

Similar companies

SCI

Service Corp International

WW International, Inc.

EVI

Evi Industries, Inc.

Compare MRM with

Compare MRM with any company

Follow MRM

Get an email when Medirom Healthcare Technologies Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow MRM: get an email when it files

Where the numbers come from

Financial figures are the values Medirom Healthcare Technologies Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.